Pith. sign in

REVIEW 1 cited by

The expected value of sample information calculations for external validation of risk prediction models

Not yet reviewed by Pith; the record is open.

This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.

SPECIMEN: schema-true, not a live event

T0 review · schema-true

One-sentence machine reading of the paper's core claim.

pith:XXXXXXXX · record.json · timestamp

arxiv 2401.01849 v3 pith:U2ZHBOCW submitted 2024-01-03 stat.AP

classification stat.AP
keywords informationvalidationsamplevalueclinicalevsiexpectedexternal
verification ladder T0 review T1 audit T2 compute T3 formal
0 comments
read the original abstract

In designing external validation studies of clinical prediction models, contemporary sample size calculation methods are based on the frequentist inferential paradigm. One of the widely reported metrics of model performance is net benefit (NB), and the relevance of conventional inference around NB as a measure of clinical utility is doubtful. Value of Information methodology quantifies the consequences of uncertainty in terms of its impact on clinical utility of decisions. We introduce the expected value of sample information (EVSI) for validation as the expected gain in NB from conducting an external validation study of a given size. We propose algorithms for EVSI computation, and in a case study demonstrate how EVSI changes as a function of the amount of current information and future study's sample size. Value of Information methodology provides a decision-theoretic lens to the process of planning a validation study of a risk prediction model and can complement conventional methods when designing such studies.

Discussion (0). Continue with ORCID to comment.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score. Full citation record

  1. Understanding algorithmic fairness for clinical prediction in terms of subgroup net benefit and health equity

    stat.AP 2024-12 conditional novelty 5.0 of 10

    Subgroup net benefit reparameterizes net benefit by including baseline prevalence, allowing clinical prediction models to be compared across protected subgroups on a utility scale.

Pith tools